Skip to main content
SpringerLink
Log in

Investigation of the relationship between disease severity and development of amyloidosis and genetic mutation in FMF disease

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Familial Mediterranean fever (FMF) is an autosomal recessive genetic disease. Amyloidosis is the most important complication of FMF that determines the prognosis of the disease.

Aims

In our study, we have investigated the relationship between the genetic mutations with the disease severity and the frequency of development of amyloidosis inpatients with FMF.

Methods

A total of 148 patients with FMF were included this study. The relationship between disease activity score, clinical findings, response to treatment, and presence of amyloid and genetic mutations were evaluated.

Results

One hundred forty-eight patients (80 women (54%), 68 men (46%)) were enrolled over 18 years of age. The mean age of the patients was 30.98 ± 11.18 (18–67) years. In our study, the most frequently seen mutations are M694V, M680I, R202Q, and E148Q, respectively. The most common genotype is M694V/M694V mutation and this mutation has been found in 37 patients (25%). In 25 patients, M694V heterozygous have been found (16.8%). The third frequent mutationis M694V/M680I/R202Q has been found in13 patients (8.7%). In 23 patients, amyloidosis has been developed. Ten patients with amyloidosis have M694V homozygous mutations (27%) and 5 patients with amyloidosis M694V heterozygous (20%) mutations. The both of the two patients who carry the homozygous E148Q mutations have developed amyloidosis.

Conclusions

In our study, the distribution of the frequency of mutations is consistent with other similar studies performed in Turkey. We found that patients with M694V mutation had a significantly higher rate of exacerbation, higher drug doses for treatment, and a close relationship with amyloidosis, as compared to patients with other mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ben-Chetrit E, Touitou I (2009) Familial Mediterranean Fever in the world. Arthritis Rheum 61:1447–1453. https://doi.org/10.1002/art.24458

    Article  CAS  PubMed  Google Scholar 

  2. Ben-Chetrit E, Yazici H (2019) Familial Mediterranean fever: different faces around the world. Clin Exp Rheumatol 37:Suppl 121–18–22

  3. Yilmaz E, Ozen S, Balci B et al (2001) Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9:553–555. https://doi.org/10.1038/sj.ejhg.5200674

    Article  CAS  PubMed  Google Scholar 

  4. Pras E, Aksentijevich I, Gruberg L et al (1992) Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 326:1509–1513. https://doi.org/10.1056/NEJM199206043262301

    Article  CAS  PubMed  Google Scholar 

  5. Levy EN, Shen Y, Kupelian A et al (1996) Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246. Am J Hum Genet 58:523–534

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Touitou I (2001) The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 9:473–483. https://doi.org/10.1038/sj.ejhg.5200658

    Article  CAS  PubMed  Google Scholar 

  7. Pras E, Livneh A, Balow JE Jr et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219. https://doi.org/10.1002/(sici)1096-8628(19980113)75:2%3c216::aid-ajmg20%3e3.0.co;2-r

    Article  CAS  PubMed  Google Scholar 

  8. Erguven M, Ucel R, Cebeci AN, Pelit M (2006) Demographic, clinical and genetic characteristics of familial Mediterranean fever and response to treatment: 120 vakalık tek merkez deneyimi. J Child Health Dis 49:283–290

    Google Scholar 

  9. Papa R, Lachmann HJ (2018) Secondary amyloidosis. Rheum Dis Clin North Am 44(585):603. https://doi.org/10.1016/j.rdc.2018.06.004

    Article  Google Scholar 

  10. Mattit H, Joma M, Al-Cheikh S et al (2006) Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrierrates and phenotype-genotype correlation. Eur J Med Genet 49:481–486. https://doi.org/10.1016/j.ejmg.2006.03.002

    Article  PubMed  Google Scholar 

  11. Nursal AF, Tekcan A, Kaya SU, Turkmen E, Yigit S (2016) Mutational spectrum of the MEFV gene in AA amyloidosis associated with familial mediterranean fever. Iran J Kidney Dis 10:107–112

    PubMed  Google Scholar 

  12. Booty MG, Chae JJ, Masters SL et al (2009) Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 60:1851–1861. https://doi.org/10.1002/art.24569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Akar N, Mısıroğlu M, Yalçınkaya F et al (2000) MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 15:118–119. https://doi.org/10.1002/(SICI)1098-1004(200001)15:1%3c118::AID-HUMU29%3e3.0.CO;2-5

    Article  CAS  PubMed  Google Scholar 

  14. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A (2002) The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 10:145–149. https://doi.org/10.1038/sj.ejhg.5200776

    Article  CAS  PubMed  Google Scholar 

  15. Livneh A, Langevitz P, Shinar Y et al (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever Amyloid: Int. J Exp Clin Invest 6:1–6. https://doi.org/10.3109/13506129908993281

    Article  CAS  Google Scholar 

  16. Kasifoglu T, Bilge SY, Sarı İ et al (2014) Amyloidosis and its related factors in Turkish patientswith familial Mediterranean fever: a multicentre study. Rheumatology 53:741–745. https://doi.org/10.1093/rheumatology/ket400

    Article  PubMed  Google Scholar 

  17. Dewalle M, Domingo C, Rozenbaum M et al (1998) Phenotype genotype correlation in Jewish patients suffering from familial Mediterranean fever: evidence for an association between Met694Val and amiloidosis. Eur J Hum Gene 6:95–97. https://doi.org/10.1038/sj.ejhg.5200170

    Article  CAS  Google Scholar 

  18. Yalçmkaya F, Çakar N, Mısırlıoğlu M et al (2000) Phenotype genotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatology 39:67–72. https://doi.org/10.1093/rheumatology/39.1.67

    Article  Google Scholar 

  19. Booth DR, Gillmore JD, Booth SE et al (1998) Pyrin/marenostrin mutations in familial Mediterranean fever. Q J Med 91:630–636. https://doi.org/10.1093/qjmed/91.9.603

    Article  Google Scholar 

  20. Chen X, Fischel-Ghodsian N, Cercek A et al (1998) Assessment of pyrin gene mutations in Turks with familial Mediterranean fever (FMF). Hum Mutat 11:456–460. https://doi.org/10.1002/(SICI)1098-1004(1998)11:6<456::AID-HUMU6>3.0.CO;2-G

  21. Yalçınkaya F, Akar N, Mısırlıoğlu M (1998) Familial Mediterranean fever- amyloidosis and the Val726Ala mutation. N Eng J Med Genet 338:993–994. https://doi.org/10.1056/NEJM199804023381414

    Article  Google Scholar 

  22. Tunca M, Akar S, Onen F et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11. https://doi.org/10.1097/01.md.0000152370.84628.0c

    Article  Google Scholar 

  23. Touitou I, Sarkisian T, Medlej-Hashim M et al (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706–1712. https://doi.org/10.1002/art.2250717

    Article  PubMed  Google Scholar 

  24. Majeed HA, Rawashdeh M, el-Shanti H et al (1999) Familial Mediterranean fever in children: the expanded clinical profile. QJM 92:309–318. https://doi.org/10.1093/qjmed/92.6.309

  25. Gedalia A, Adar A, Gorodischer R (1992) Familial Mediterranean fever in children J Rheumatol Suppl 35:1–9

    CAS  PubMed  Google Scholar 

  26. Bilge SY, Sari I, Solmaz D et al (2019) The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia. Turk J Med Sci 18:472–477. https://doi.org/10.3906/sag-1809-100

    Article  CAS  Google Scholar 

  27. Ozcan AG, Sayin DB, Misirlioğlu ED et al (2009) The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kirikkale University in Turkey. Mol Biol Rep 36:757–760. https://doi.org/10.1007/s11033-008-9240-9245

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Prof. Dr. Hasan Önder, faculty member of 19 Mayıs University Faculty of Agriculture, Department of Zootechnics, who contributed to the statistical evaluation of the study.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Ondokuz Mayis University, Samsun, Turkey

    Berk Bas & Zeliha Yarar

  2. Department of Nephrology Ondokuz, Mayis University, Samsun, Turkey

    Hayriye Sayarlioglu, Melda Dilek & Nurol Arik

  3. Department of Rheumatology, Ondokuz Mayis University, Samsun, Turkey

    Mehmet Sayarlioglu

Authors
  1. Berk Bas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hayriye Sayarlioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zeliha Yarar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Melda Dilek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nurol Arik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mehmet Sayarlioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hayriye Sayarlioglu.

Ethics declarations

Ethics approval

Ethics committee approval, numbered B.30.2.ODM.0.20.08/225–296 and dated 17.05.2016, was obtained from the Ethics Committee of Ondokuz Mayıs University Faculty of Medicine. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants involved in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bas, B., Sayarlioglu, H., Yarar, Z. et al. Investigation of the relationship between disease severity and development of amyloidosis and genetic mutation in FMF disease. Ir J Med Sci 192, 1497–1503 (2023). https://doi.org/10.1007/s11845-022-03108-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-022-03108-5

Keywords

Search

Navigation